Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer

EMBO Molecular Medicine

Volumn 6, Issue 1, 2014, Pages 80-98

  Montagner, Alexandra ^a,c   Delgado, Maria B ^a   Tallichet Blanc, Corinne ^a   Chan, Jeremy S K ^b   Sng, Ming K ^b   Mottaz, Hélène ^a   Degueurce, Gwendoline ^a   Lippi, Yannick ^c   Moret, Catherine ^a   Baruchet, Michael ^a   Antsiferova, Maria ^d   Werner, Sabine ^d   Hohl, Daniel ^e   Al Saati, Talal ^f   Farmer, Pierre J ^g,j   Tan, Nguan S ^b,h   Michalik, Liliane ^a   Wahli, Walter ^a,i  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^d ETH ZURICH   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f CHU PURPAN   (France)

^g MERCK SERONO S A   (Switzerland)

^h INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

ⁱ NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^j NOVARTIS PHARMA AG   (Switzerland)

more..

Author keywords

Keratinocyte; PPAR beta delta; Skin cancer; Src; UV

Indexed keywords

3 [(4 ANILINO 2 METHOXYPHENYL)SULFAMOYL] 2 THENOIC ACID METHYL ESTER; CELL NUCLEUS RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; TRANSFORMING GROWTH FACTOR BETA1;

ACTINIC KERATOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NORMAL HUMAN; ONCOGENE SRC; PRIORITY JOURNAL; RADIATION INDUCED NEOPLASM; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARCINOMA; TUMOR GROWTH; ULTRAVIOLET RADIATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; ENZYME ACTIVATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, HAIRLESS; MICE, KNOCKOUT; PPAR DELTA; PPAR-BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; SRC-FAMILY KINASES; ULTRAVIOLET RAYS;

EID: 84891960081     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201302666     Document Type: Article

References (75)

1. Adhikary T, Brandt DT, Kaddatz K, Stockert J, Naruhn S, Meissner W, Finkernagel F, Obert J, Lieber S, Scharfe M, et al (2012) Inverse PPARbeta/delta agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion. Oncogene DOI: 10.1038/onc.2012.549
2. Allalou A, Wahlby C (2009) BlobFinder, a tool for fluorescence microscopy image cytometry. Comput Methods Programs Biomed 94: 58-65
3. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1: 46-54
4. Bode AM, Dong Z (2003) Mitogen-activated protein kinase activation in UV-induced signal transduction. Sci STKE 2003: RE2
5. Boukamp P (2005) Non-melanoma skin cancer: What drives tumor development and progression? Carcinogenesis 26: 1657-1667
6. Broders AC (1921) Squamous-cell epithelioma of the skin: A study of 256 cases. Ann Surg 73: 141-160
7. Burdick AD, Bility MT, Girroir EE, Billin AN, Willson TM, Gonzalez FJ, Peters JM (2007) Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes. Cell Signal 19: 1163-1171
8. Campbell C, Quinn AG, Rees JL (1993) Codon 12 Harvey-ras mutations are rare events in non-melanoma human skin cancer. Br J Dermatol 128: 111-114
9. Cataisson C, Joseloff E, Murillas R, Wang A, Atwell C, Torgerson S, Gerdes M, Subleski J, Gao JL, Murphy PM, et al (2003) Activation of cutaneous protein kinase C alpha induces keratinocyte apoptosis and intraepidermal inflammation by independent signaling pathways. J Immunol 171: 2703-2713
10. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, van de Rijn M, Botstein D, Brown PO (2004) Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds. PLoS Biol 2: E7
11. Chen C, Mendez E, Houck J, Fan W, Lohavanichbutr P, Doody D, Yueh B, Futran ND, Upton M, Farwell DG, et al (2008) Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 17: 2152-2162
12. Clemmensen A, Thomassen M, Clemmensen O, Tan Q, Kruse TA, Petersen TK, Andersen F, Andersen KE (2009) Extraction of high-quality epidermal RNA after ammonium thiocyanate-induced dermo-epidermal separation of 4 mm human skin biopsies. Exp Dermatol 18: 979-984
13. Devary Y, Rosette C, DiDonato JA, Karin M (1993) NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 261: 1442-1445
14. Di-Poi N, Tan NS, Michalik L, Wahli W, Desvergne B (2002) Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell 10: 721-733
15. Ehrhart JC, Gosselet FP, Culerrier RM, Sarasin A (2003) UVB-induced mutations in human key gatekeeper genes governing signalling pathways and consequences for skin tumourigenesis. Photochem Photobiol Sci 2: 825-834
16. Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, Andre S, Piccart M, Campone M, Brain E, et al (2009) A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 15: 68-74
17. Fitsialos G, Chassot AA, Turchi L, Dayem MA, LeBrigand K, Moreilhon C, Meneguzzi G, Busca R, Mari B, Barbry P, et al (2007) Transcriptional signature of epidermal keratinocytes subjected to in vitro scratch wounding reveals selective roles for ERK1/2, p38, and phosphatidylinositol 3-kinase signaling pathways. J Biol Chem 282: 15090-15102
18. Fritsche E, Schafer C, Calles C, Bernsmann T, Bernshausen T, Wurm M, Hubenthal U, Cline JE, Hajimiragha H, Schroeder P, et al (2007) Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci U S A 104: 8851-8856
19. Genini D, Garcia-Escudero R, Carbone GM, Catapano CV (2012) Transcriptional and non-transcriptional functions of PPARbeta/delta in non-small cell lung cancer. PLoS One 7: e46009
20. Glick AB (2012) The role of TGFbeta signaling in squamous cell cancer: Lessons from mouse models. J Skin Cancer 2012: 249063
21. Guasch G, Schober M, Pasolli HA, Conn EB, Polak L, Fuchs E (2007) Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. Cancer Cell 12: 313-327
22. Gupta RA, Wang D, Katkuri S, Wang H, Dey SK, DuBois RN (2004) Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth. Nat Med 10: 245-247
23. Hameetman L, Commandeur S, Bavinck JN, Wisgerhof HC, de Gruijl FR, Willemze R, Mullenders L, Tensen CP, Vrieling H (2013) Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients. BMC Cancer 13: 58
24. Han G, Lu SL, Li AG, He W, Corless CL, Kulesz-Martin M, Wang XJ (2005) Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 115: 1714-1723
25. Harman FS, Nicol CJ, Marin HE, Ward JM, Gonzalez FJ, Peters JM (2004) Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis. Nat Med 10: 481-483
26. Hollingshead HE, Borland MG, Billin AN, Willson TM, Gonzalez FJ, Peters JM (2008) Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. Carcinogenesis 29: 169-176
27. Hoot KE, Lighthall J, Han G, Lu SL, Li A, Ju W, Kulesz-Martin M, Bottinger E, Wang XJ (2008) Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest 118: 2722-2732
28. Joseloff E, Cataisson C, Aamodt H, Ocheni H, Blumberg P, Kraker AJ, Yuspa SH (2002) Src family kinases phosphorylate protein kinase C delta on tyrosine residues and modify the neoplastic phenotype of skin keratinocytes. J Biol Chem 277: 12318-12323
29. Kannan-Thulasiraman P, Seachrist DD, Mahabeleshwar GH, Jain MK, Noy N (2010) Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth. J Biol Chem 285: 19106-19115
30. Kersten S, Mandard S, Tan NS, Escher P, Metzger D, Chambon P, Gonzalez FJ, Desvergne B, Wahli W (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 275: 28488-28493
31. Kim DJ, Akiyama TE, Harman FS, Burns AM, Shan W, Ward JM, Kennett MJ, Gonzalez FJ, Peters JM (2004) Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis. J Biol Chem 279: 23719-23727
32. Kopetz S, Shah AN, Gallick GE (2007) Src continues aging: Current and future clinical directions. Clin Cancer Res 13: 7232-7236
33. Lieu FM, Yamanishi K, Konishi K, Kishimoto S, Yasuno H (1991) Low incidence of Ha-ras oncogene mutations in human epidermal tumors. Cancer Lett 59: 231-235
34. Lohavanichbutr P, Mendez E, Holsinger FC, Rue TC, Zhang Y, Houck J, Upton MP, Futran N, Schwartz SM, Wang P, et al (2013) A 13-gene signature prognostic of HPV-negative OSCC: Discovery and external validation. Clin Cancer Res 19: 1197-1203
35. Madan V, Lear JT, Szeimies RM (2010) Non-melanoma skin cancer. Lancet 375: 673-685
36. Martins VL, Vyas JJ, Chen M, Purdie K, Mein CA, South AP, Storey A, McGrath JA, O'Toole EA (2009) Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen. J Cell Sci 122: 1788-1799
37. Matsumoto T, Jiang J, Kiguchi K, Ruffino L, Carbajal S, Beltran L, Bol DK, Rosenberg MP, DiGiovanni J (2003) Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis. Cancer Res 63: 4819-4828
38. Matsumoto T, Kiguchi K, Jiang J, Carbajal S, Ruffino L, Beltran L, Wang XJ, Roop DR, DiGiovanni J (2004) Development of transgenic mice that inducibly express an active form of c-Src in the epidermis. Mol Carcinog 40: 189-200
39. Matsumura Y, Ananthaswamy HN (2002) Short-term and long-term cellular and molecular events following UV irradiation of skin: Implications for molecular medicine. Expert Rev Mol Med 4: 1-22
40. Matsumura Y, Ananthaswamy HN (2004) Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 195: 298-308
41. Michalik L, Desvergne B, Tan NS, Basu-Modak S, Escher P, Rieusset J, Peters JM, Kaya G, Gonzalez FJ, Zakany J, et al (2001) Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J Cell Biol 154: 799-814
42. Michalik L, Desvergne B, Wahli W (2004) Peroxisome-proliferator-activated receptors and cancers: Complex stories. Nat Rev Cancer 4: 61-70
43. Michalik L, Feige JN, Gelman L, Pedrazzini T, Keller H, Desvergne B, Wahli W (2005) Selective expression of a dominant-negative form of peroxisome proliferator-activated receptor in keratinocytes leads to impaired epidermal healing. Mol Endocrinol 19: 2335-2348
44. Montagner A, Rando G, Degueurce G, Leuenberger N, Michalik L, Wahli W (2011) New insights into the role of PPARs. Prostaglandins Leukot Essent Fatty Acids
45. Muller-Brusselbach S, Komhoff M, Rieck M, Meissner W, Kaddatz K, Adamkiewicz J, Keil B, Klose KJ, Moll R, Burdick AD, et al (2007) Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice. EMBO J 26: 3686-3698
46. Nakamura M, Tokura Y (2011) Epithelial-mesenchymal transition in the skin. J Dermatol Sci 61: 7-13
47. Newkirk KM, Parent AE, Fossey SL, Choi C, Chandler HL, Rajala-Schultz PJ, Kusewitt DF (2007) Snai2 expression enhances ultraviolet radiation-induced skin carcinogenesis. Am J Pathol 171: 1629-1639
48. Nijsten T, Geluyckens E, Colpaert C, Lambert J (2005) Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors. J Cutan Pathol 32: 340-347
49. Nuyten DS, van de Vijver MJ (2006) Gene expression signatures to predict the development of metastasis in breast cancer. Breast Dis 26: 149-156
50. Ooi EM, Watts GF, Sprecher DL, Chan DC, Barrett PH (2011) Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity. J Clin Endocrinol Metab 96: E1568-E1576
51. Park BH, Vogelstein B, Kinzler KW (2001) Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci U S A 98: 2598-2603
52. Peters JM, Gonzalez FJ (2009) Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer. Biochim Biophys Acta 1796: 230-241
53. Peters JM, Shah YM, Gonzalez FJ (2012) The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer 12: 181-195
54. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN (1991) Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 4: 196-202
55. Reed KR, Sansom OJ, Hayes AJ, Gescher AJ, Winton DJ, Peters JM, Clarke AR (2004) PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine. Oncogene 23: 8992-8996
56. Rho O, Kim DJ, Kiguchi K, Digiovanni J (2011) Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Mol Carcinog 50: 264-279
57. Rieck M, Meissner W, Ries S, Muller-Brusselbach S, Muller R (2008) Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: A comparative analysis of PPAR-selective agonists and all-trans retinoic acid. Mol Pharmacol 74: 1269-1277
58. Romanowska M, Reilly L, Palmer CN, Gustafsson MC, Foerster J (2010) Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo. PLoS One 5: e9701
59. Rowert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, Sterry W, Stockfleth E (2007) Actinic keratosis is an early in situ squamous cell carcinoma: A proposal for reclassification. Br J Dermatol 156(3): 8-12
60. Schafer M, Werner S (2008) Cancer as an overhealing wound: An old hypothesis revisited. Nat Rev Mol Cell Biol 9: 628-638
61. Schug TT, Berry DC, Shaw NS, Travis SN, Noy N (2007) Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129: 723-733
62. Schug TT, Berry DC, Toshkov IA, Cheng L, Nikitin AY, Noy N (2008) Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proc Natl Acad Sci U S A 105: 7546-7551
63. Seo HR, Kwan YW, Cho CK, Bae S, Lee SJ, Soh JW, Chung HY, Lee YS (2004) PKCalpha induces differentiation through ERK1/2 phosphorylation in mouse keratinocytes. Exp Mol Med 36: 292-299
64. Serrels B, Serrels A, Mason SM, Baldeschi C, Ashton GH, Canel M, Mackintosh LJ, Doyle B, Green TP, Frame MC, et al (2009) A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model. Carcinogenesis 30: 249-257
65. Sertznig P, Seifert M, Tilgen W, Reichrath J (2008) Peroxisome proliferator-activated receptors (PPARs) and the human skin: Importance of PPARs in skin physiology and dermatologic diseases. Am J Clin Dermatol 9: 15-31
66. Tan NS, Icre G, Montagner A, Bordier-ten-Heggeler B, Wahli W, Michalik L (2007) The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration. Mol Cell Biol 27: 7161-7175
67. Tan NS, Michalik L, Di-Poi N, Ng CY, Mermod N, Roberts AB, Desvergne B, Wahli W (2004) Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression. EMBO J 23: 4211-4221
68. Tan NS, Michalik L, Noy N, Yasmin R, Pacot C, Heim M, Fluhmann B, Desvergne B, Wahli W (2001) Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev 15: 3263-3277
69. Trifan OC, Hla T (2003) Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 7: 207-222
70. Wang D, Wang H, Guo Y, Ning W, Katkuri S, Wahli W, Desvergne B, Dey SK, DuBois RN (2006) Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression. Proc Natl Acad Sci U S A 103: 19069-19074
71. Wang HQ, Smart RC (1999) Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion. J Cell Sci 112(20): 3497-3506
72. Westergaard M, Henningsen J, Johansen C, Rasmussen S, Svendsen ML, Jensen UB, Schroder HD, Staels B, Iversen L, Bolund L, et al (2003) Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. J Invest Dermatol 121: 1104-1117
73. Yagi R, Waguri S, Sumikawa Y, Nada S, Oneyama C, Itami S, Schmedt C, Uchiyama Y, Okada M (2007) C-terminal Src kinase controls development and maintenance of mouse squamous epithelia. EMBO J 26: 1234-1244
74. Yoshinaga M, Taki K, Somada S, Sakiyama Y, Kubo N, Kaku T, Tsuruta S, Kusumoto T, Sakai H, Nakamura K, et al (2011) The expression of both peroxisome proliferator-activated receptor delta and cyclooxygenase-2 in tissues is associated with poor prognosis in colorectal cancer patients. Dig Dis Sci 56: 1194-1200
75. Zuo X, Peng Z, Moussalli MJ, Morris JS, Broaddus RR, Fischer SM, Shureiqi I (2009) Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis. J Natl Cancer Inst 101: 762-767